Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 368.69 | - | - | - | - |
Total Expenses | 379.77 | - | - | - | - |
Profit Before Tax | -11.07 | - | - | - | - |
Profit After Tax | -9.07 | - | - | - | - |
Operating Profit after Depreciation | 2.84 | - | - | - | - |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 155.40 | - | - | - | - |
Total Non Current Assets | 157.70 | - | - | - | - |
Total Current Assets | 176 | - | - | - | - |
TOTAL ASSETS | 333.70 | - | - | - | - |
Total Shareholder's Fund | 135.79 | - | - | - | - |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | 3.91 | - | - | - | - |
Net Cash used in Investing Activities | -11.83 | - | - | - | - |
Net Cash used in Financing Activities | 5.23 | - | - | - | - |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 368.69 | 372.69 | 451.16 | 384.70 | 283.53 |
Total Expenses | 379.75 | 370.47 | 423.42 | 345.18 | 277.28 |
Profit Before Tax | -11.06 | 2.21 | 27.73 | 39.52 | 6.25 |
Profit After Tax | -9.05 | 1.27 | 19.66 | 27.97 | 8.25 |
Operating Profit after Depreciation | 2.86 | 15.17 | 38.89 | 48.85 | 16.66 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 155.04 | 151.85 | 140.49 | 119.30 | 101.07 |
Total Non Current Assets | 157.36 | 154.72 | 143.39 | 130.19 | 111.49 |
Total Current Assets | 199.78 | 203.26 | 185.03 | 133.92 | 119.17 |
TOTAL ASSETS | 357.14 | 357.98 | 328.43 | 264.11 | 230.67 |
Total Shareholder's Fund | 142.35 | 151.96 | 150.56 | 130.79 | 103.94 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | 12.17 | 38.08 | 25.71 | 27.55 | 30.55 |
Net Cash used in Investing Activities | -17.91 | -22.17 | -27.33 | -31.29 | -6.87 |
Net Cash used in Financing Activities | 5.70 | -16.82 | 2.98 | 2.70 | -23.48 |
Particulars (in ₹ Cr.) | 2024-12 | 2024-09 | 2024-06 | 2024-03 | 2023-12 |
---|---|---|---|---|---|
Total Revenue | 88.71 | 79.94 | 76.54 | 102.24 | 97.34 |
Total Expenses | 79.94 | 71.24 | 68.34 | 90.54 | 90.36 |
Profit Before Tax | 1.37 | 1.20 | 0.59 | 3.94 | 0.04 |
Profit After Tax | 1.29 | 2.69 | 2.68 | 3.53 | 0.50 |
Operating Profit after Depreciation | 8.91 | 8.84 | 8.22 | 11.75 | 6.98 |
Particulars (in ₹ Cr.) | 2024-12 | 2024-09 | 2024-06 | 2024-03 | 2023-12 |
---|---|---|---|---|---|
Total Revenue | 88.71 | 79.94 | 76.54 | 102.24 | 97.34 |
Total Expenses | 79.94 | 71.25 | 68.35 | 90.53 | 90.36 |
Profit Before Tax | 1.48 | 1.19 | 0.59 | 3.95 | 0.05 |
Profit After Tax | 1.40 | 2.69 | 2.68 | 3.55 | 0.50 |
Operating Profit after Depreciation | 8.90 | 8.83 | 8.21 | 11.76 | 6.98 |
Company | Price | Market Cap (in ₹ Cr) |
---|---|---|
Mangalam Drugs and Organics Ltd | ₹100.35 | ₹158.84 |
Sun Pharmaceuticals Industries Ltd | ₹1,613.65 | ₹3,87,168.69 |
Divis Laboratories Ltd | ₹5,725.20 | ₹1,51,986.07 |
Cipla Ltd | ₹1,463.25 | ₹1,18,174.12 |
Torrent Pharmaceuticals Ltd | ₹3,028.40 | ₹1,02,490.21 |
Mankind Pharma Ltd | ₹2,337.05 | ₹96,421.67 |
On 13 February 2025
06 Feb 2025, 04:48 pm
16 Jan 2025, 02:54 pm
Soma Textiles & Industries Ltd, Saraswati Saree Depot Ltd, Pudumjee Paper Products Ltd and Balaji Telefilms Ltd are among the other gainers in the BSE's 'B' group today, 29 November 2024.
29 Nov 2024, 12:15 pm
On 14 November 2024
08 Nov 2024, 04:41 pm
On 26 September 2024
25 Sep 2024, 10:25 am